Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000210233 | SCV002817131 | likely benign | Hypercholesterolemia, familial, 1 | 2022-08-29 | reviewed by expert panel | curation | The NM_000527.5(LDLR): c.1194C>T (p.Ile398=) variant is classified as Likely Benign for Familial Hypercholesterolemia by applying evidence code BS1, BP4 and BP7 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: BS1 - FAF = 0.00448 (0.448%) in East Asian exomes (gnomAD v2.1.1). BP4 - No REVEL, splicing evaluation required. Functional data on splicing not available. Variant is not located within the limits of canonical splicing sites Variant is exonic and at least 50bp upstream from canonical donor site but does not creates AG There is no AG Nearby Variant is not predicted to alter splicing. BP7 - Variant is synonymous and meets BP4 |
Cardiovascular Biomarker Research Laboratory, |
RCV000210233 | SCV000266323 | likely benign | Hypercholesterolemia, familial, 1 | 2016-08-31 | criteria provided, single submitter | research | MAF =<0.3% |
LDLR- |
RCV000210233 | SCV000295287 | benign | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Invitae | RCV000858408 | SCV000556771 | benign | Familial hypercholesterolemia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000210233 | SCV000689759 | benign | Hypercholesterolemia, familial, 1 | 2017-07-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000210233 | SCV001286368 | benign | Hypercholesterolemia, familial, 1 | 2018-08-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Pars Genome Lab | RCV000210233 | SCV001736823 | likely benign | Hypercholesterolemia, familial, 1 | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001723783 | SCV001949524 | benign | not provided | 2020-01-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17347910, 32719484) |
Ce |
RCV001723783 | SCV002063727 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | LDLR: BP4, BP7 |
Ambry Genetics | RCV002336587 | SCV002644824 | likely benign | Cardiovascular phenotype | 2016-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
U4M - |
RCV000210233 | SCV000583803 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2017-03-30 | flagged submission | clinical testing | |
Natera, |
RCV001272182 | SCV001453897 | benign | Autosomal dominant familial hypercholesterolemia | 2020-05-30 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001699012 | SCV001920104 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723783 | SCV001969926 | likely benign | not provided | no assertion criteria provided | clinical testing |